Endogenous peptide hormone

Atrial Natriuretic Peptide

An endogenous cardiac peptide that promotes natriuresis, vasodilation and suppression of the renin-aldosterone system.

Sequence
SLRRSSCFGGRIDRIGAQSGLGCNSFRY
Formula
C127H203N45O39S3
Molecular weight
3080.5 Da

Evidence confidence

Human
Not yet assessed
Trust Engine review pending.
Animal
Not yet assessed
Trust Engine review pending.
Mechanistic
Not yet assessed
Trust Engine review pending — see editorial links below.
Editorial evidence links exist, but this category has not yet completed Trust Engine assessment.
Safety
Not yet assessed
Trust Engine review pending.

Claimed uses

Mechanisms

Safety notes

Exogenous ANP can cause hypotension, dizziness, altered renal function and fluid or electrolyte disturbances. Medical monitoring is required.

Regulation
  • Therapeutic availability and approval vary by jurisdiction; not approved for general wellness, weight loss or performance use.

References

  1. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications · 2006
Last reviewed
12 July 2026
Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.